Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

SARMs work differently in tissues due to unique interactions and structures.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Anastrozole and cyproterone acetate treatment can help increase adult height in boys with testotoxicosis.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Some dibenzo compounds might help treat cancer with fewer side effects.